ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IκB/NF-κB and Keap1/Nrf2 Signaling Pathways

Luo, Liang-Pu; Suo, Ping; Ren, Li-Li; Liu, Hong-Jiao; Zhang, Yamei; Zhao, Ying-Yong*南方医科大学; 西北大学
Frontiers in Pharmacology2021-12-22DOI: 10.3389/fphar.2021.800522
40被引19阅读
引用收藏
分享

摘要

Oxidative stress and inflammation are important and critical mediators in the development and progression of chronic kidney disease (CKD) and its complications. Shenkang injection (SKI) has been widely used to treat patients with CKD. Although the anti-oxidative and anti-inflammatory activity was involved in SKI against CKD, its bioactive components and underlying mechanism remain enigmatic. A rat model of adenine-induced chronic renal failure (CRF) is associated with, and largely driven by, oxidative stress and inflammation. Hence, we identified the anti-oxidative and anti-inflammatory components of SKI and further revealed their underlying mechanism in the adenine-induced CRF rats. Compared with control rats, the levels of creatinine, urea, uric acid, total cholesterol, triglyceride, and low-density lipoprotein cholesterol in serum were significantly increased in the adenine-induced CRF rats. However, treatment with SKI and its three anthraquinones including chrysophanol, emodin, and rhein could reverse these aberrant changes. They could significantly inhibit pro-fibrotic protein expressions including collagen I, alpha-SMA, fibronectin, and vimentin in the kidney tissues of the adenine-induced CRF rats. Of note, SKI and rhein showed the stronger inhibitory effect on these pro-fibrotic protein expressions than chrysophanol and emodin. Furthermore, they could improve dysregulation of Ix199;B/NF-B and Keap1/Nrf2 signaling pathways. Chrysophanol and emodin showed the stronger inhibitory effect on the NF-kappa B p65 protein expression than SKI and rhein. Rhein showed the strongest inhibitory effect on p65 downstream target gene products including NAD(P)H oxidase subunits (p47(phox), p67(phox), and gp91(phox)) and COX-2, MCP-1, iNOS, and 12-LO in the kidney tissues. However, SKI and rhein showed the stronger inhibitory effect on the significantly downregulated anti-inflammatory and anti-oxidative protein expression nuclear Nrf2 and its target gene products including HO-1, catalase, GCLC, and NQO1 in the Keap1/Nrf2 signaling pathway than chrysophanol and emodin. This study first demonstrated that SKI and its major components protected against renal fibrosis by inhibiting oxidative stress and inflammation via simultaneous targeting Ix199;B/NF-B and Keap1/Nrf2 signaling pathways, which illuminated the potential molecular mechanism of anti-oxidative and anti-inflammatory effects of SKI.

学科与关键词

关键词
chronic kidney diseaseshenkang injectionchrysophanol (PubChem CID10208)emodinrhein (PubChem CID10168)oxidative stress and inflammationlkBNF-kB signaling pathwayKeap1Nrf2 signaling pathway
相关
加载中…
  • Jian-Pi-Yi-Shen Formula Ameliorates Oxidative Stress, Inflammation, and Apoptosis by Activating the Nrf2 Signaling in 5/6 Nephrectomized Rats
    Zhou, Fanyuan; Zou, Xiaohu; Zhang, Jing; Wang, Ziwei; Yang, Yajun*; Wang, Dongtao*Frontiers in Pharmacology, 2021, 12: 630210.被引 15
  • Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT
    Li, Run; Shi, Chunru; Wei, Cuiting; Wang, Chao; Du, Hongjian; Liu, Ran; Wang, Xu; Hong, Quan*; Chen, Xiangmei*PHYTOMEDICINE, 2023, 116: 154873.被引 1
  • Astragaloside IV protects against ischemia/reperfusion (I/R)-induced kidney injury based on the Keap1-Nrf2/ARE signaling pathway
    Su, Yanyan; Xu, Jiaqi; Chen, Siqi; Feng, Junxia; Li, Jingchun; Lei, Zihan; Qiao, Lingyan; Wang, Yaning*; Zeng, Dewang*Translational Andrology and Urology, 2022, 11(8): 1177-1188.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-12-22
卷期
第 12 卷
页码
800522
DOI
10.3389/fphar.2021.800522
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Shaanxi Key Science and Technology Plan Project [2019ZDLSF04-04-02]; National Key Research and Development Project [2019YFC1709405]; National Natural Science Foundation of China [82074002, 818729858]

作者

  • L

    Luo, Liang-Pu (第一作者)

    southern med univ · northwest univ

  • S

    Suo, Ping

    northwest univ

查看全部 6 位作者收起作者
  • R

    Ren, Li-Li

    northwest univ

  • L

    Liu, Hong-Jiao

    northwest univ

  • Z

    Zhang, Yamei

    chengdu univ

  • Z

    Zhao, Ying-Yong (通讯)

    northwest univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417